A Simulation Framework for Modeling the Within-Patient Evolutionary Dynamics of SARS-CoV-2

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

The global impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to considerable interest in detecting novel beneficial mutations and other genomic changes that may signal the development of variants of concern (VOCs). The ability to accurately detect these changes within individual patient samples is important in enabling early detection of VOCs. Such genomic scans for rarely acting positive selection are best performed via comparison of empirical data with simulated data wherein commonly acting evolutionary factors, including mutation and recombination, reproductive and infection dynamics, and purifying and background selection, can be carefully accounted for and parameterized. Although there has been work to quantify these factors in SARS-CoV-2, they have yet to be integrated into a baseline model describing intrahost evolutionary dynamics. To construct such a baseline model, we develop a simulation framework that enables one to establish expectations for underlying levels and patterns of patient-level variation. By varying eight key parameters, we evaluated 12,096 different model–parameter combinations and compared them with existing empirical data. Of these, 592 models (∼5%) were plausible based on the resulting mean expected number of segregating variants. These plausible models shared several commonalities shedding light on intrahost SARS-CoV-2 evolutionary dynamics: severe infection bottlenecks, low levels of reproductive skew, and a distribution of fitness effects skewed toward strongly deleterious mutations. We also describe important areas of model uncertainty and highlight additional sequence data that may help to further refine a baseline model. This study lays the groundwork for the improved analysis of existing and future SARS-CoV-2 within-patient data.

Original languageEnglish
Article numberevad204
JournalGenome Biology and Evolution
Volume15
Issue number11
DOIs
StatePublished - Nov 1 2023

Funding

Research reported in this manuscript was supported by the National Institute of General Medical Sciences of the National Institutes of Health (NIH) under award number P30GM140963 (to J.M.G. and B.S.C.) and by U54GM104940, which funds the Louisiana Clinical and Translational Science Center. NIH awards R35GM124701 (BSC) and R35GM139383 (JDJ) also supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We are grateful to Parul Johri and Vivak Soni for their advice regarding simulation design. We would also like to thank the computing resources used during this study: the common burn-in and rerun replicates were run on the Agave computing cluster at ASU; all other simulation replicates were run using the Open Science Pool resources (, , ).

Funder number
R35GM139383, R35GM124701, U54GM104940, P30GM140963

    Keywords

    • SARS-CoV-2
    • evolutionary genomics
    • population genetics
    • viral evolution

    Fingerprint

    Dive into the research topics of 'A Simulation Framework for Modeling the Within-Patient Evolutionary Dynamics of SARS-CoV-2'. Together they form a unique fingerprint.

    Cite this